Company Analysis Sun Pharmaceutical Industries Limited
1. Summary
Advantages
- Dividends (0.7991%) are higher than the sector average (0.6379%).
- The stock's return over the last year (9.3%) is higher than the sector average (-37.46%).
- Current debt level 3.33% is below 100% and has decreased over 5 years from 15.14%.
- The company's current efficiency (ROE=16.01%) is higher than the sector average (ROE=3.58%)
Disadvantages
- Price (1757.7 βΉ) is higher than fair price (555.5 βΉ)
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Sun Pharmaceutical Industries Limited | Healthcare | Index | |
|---|---|---|---|
| 7 days | 0.4% | 0.8% | 1.6% |
| 90 days | -4.6% | -14.9% | -1.4% |
| 1 year | 9.3% | -37.5% | 7.1% |
SUNPHARMA vs Sector: Sun Pharmaceutical Industries Limited has outperformed the "Healthcare" sector by 46.76% over the past year.
SUNPHARMA vs Market: Sun Pharmaceutical Industries Limited has outperformed the market by 2.22% over the past year.
Stable price: SUNPHARMA is not significantly more volatile than the rest of the market on "Bombay Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: SUNPHARMA with weekly volatility of 0.1789% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (1757.7 βΉ) is higher than the fair price (555.5 βΉ).
Price is higher than fair: The current price (1757.7 βΉ) is 68.4% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (40.29) is lower than that of the sector as a whole (59.48).
P/E vs Market: The company's P/E (40.29) is lower than that of the market as a whole (44.4).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (5.75) is lower than that of the sector as a whole (8.7).
P/BV vs Market: The company's P/BV (5.75) is lower than that of the market as a whole (6.26).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (8.08) is lower than that of the sector as a whole (18.4).
P/S vs Market: The company's P/S indicator (8.08) is lower than that of the market as a whole (8.99).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (19.65) is higher than that of the sector as a whole (4.22).
EV/Ebitda vs Market: The company's EV/Ebitda (19.65) is higher than that of the market as a whole (15.13).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 30.87% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (30.87%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-17.15%).
5.4. ROE
ROE vs Sector: The company's ROE (16.01%) is higher than that of the sector as a whole (3.58%).
ROE vs Market: The company's ROE (16.01%) is higher than that of the market as a whole (-1.32%).
5.5. ROA
ROA vs Sector: The company's ROA (11.52%) is higher than that of the sector as a whole (3.38%).
ROA vs Market: The company's ROA (11.52%) is higher than that of the market as a whole (7.54%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (18.19%) is higher than that of the sector as a whole (11.26%).
ROIC vs Market: The company's ROIC (18.19%) is higher than that of the market as a whole (16.2%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 0.7991% is higher than the average for the sector '0.6379%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 0.7991% has been steadily paid over the past 7 years, DSI=1.
Dividend growth: Company's dividend yield 0.7991% has been growing over the last 5 years. Growth over 5 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (30.26%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
